Accord BioPharma

Breaking: We’re proud to share the FDA has approved the 420mg strength of our first #biosimilar in the US. This pivotal approval will impact patient populations experiencing several forms of HER2-overexpressing cancer. It is a critical milestone in our mission to improve access by providing people experiencing some of the most common types of cancer with additional treatment options.      We're thankful to our development partner Shanghai Henlius Biotech, Inc., and look forward to sharing information in the future regarding product availability.      Learn more: prn.to/4esZxQt

Test your #BreastCancerAwareness

#Breaking: We’re proud to share the FDA has approved our #biosimilar for certain chronic inflammatory conditions.    This approval reinforces our mission to expand the availability of affordable treatment options that provide similar safety and efficacy to current standard of care, improving access for people living with these conditions.    Learn more: https://prn.to/3BMB0rI

What’s in the name for biosimilars?    Originator biologics and biosimilars share the same established drug name but differ in their unique 4-letter suffixes. This distinction helps in clear identification and promotes pharmacovigilance, without implying any clinically meaningful safety or efficacy differences. And just like their reference molecule, all therapies are thoroughly evaluated by the FDA.    To learn more about some of the most common #biosimilars questions, visit our site: bit.ly/3S9E2vl

Last month, our SVP Digital and Marketing Strategy & Operations, Nuvan Augustin Dassanaike, presented at the BioTechX USA 2024 Conference in Philadelphia. The event featured speakers from the top 50 pharmaceutical and biotech companies, healthcare systems and academic groups, with a focus on enhancing collaboration and networking opportunities. This flagship event for decision-makers and thought leaders covered diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare.       He shared insights on how data-driven strategies can transform commercialization success in the life sciences industry. From initial research to market launch, data-centric approaches can revolutionize how new products are developed and introduced to market.     At Accord BioPharma, our mission is to harness the power of data to improve patient outcomes through a holistic approach. Our commitment to innovation and excellence aligns perfectly with the theme of this year’s conference, and we are excited to continue pushing the boundaries of what’s possible.      We look forward to next year’s event and the continued collaboration with such a passionate and forward-thinking community!      #BioTechXUSA2024 

For years, our colleagues have committed themselves to delivering treatments that positively impact patients’ lives. They’ve done so while adding a humanizing twist.    At our Town Hall last month, our colleagues shared exciting updates and future plans. It was an opportunity to celebrate our collective achievements and look ahead to innovative projects on the horizon.     Through thoughtful conversation, we reflected on our mission: addressing tough-to-treat therapeutic areas with proven, patient-friendly therapies. Our commitment to providing high-quality, affordable treatments remains unwavering.     Thank you to our dedicated team for their relentless efforts. Together, we are transforming healthcare and making a difference in patients’ lives.  

#DidYouKnow? Most people have no external symptoms of #ProstateCancer. The clearest signs are found by testing. It’s time for a can-do attitude—have a PRO-STATE of Mind and get screened. Learn more about symptoms with ZERO Prostate Cancer at https://lnkd.in/gYA4TTZn #GetScreened #ImPROstateofmind #PROstateofmind #PROstatefacts #ProstateCancerAwareness #ProstateCancerAwarenessMonth

What is #ProstateCancer? Who does it impact? What are the symptoms? As #ProstateCancerAwarenessMonth comes to an end, view the StoryMD health guide to discover answers to all these questions and more: bit.ly/3Ryr9vs

#GetInvolved this #ProstateCancerAwarenessMonth. It’s “simple” to sign up and participate in an upcoming ZERO Prostate Cancer walk/run. Our team will be there alongside UroPartners LLC. on Sept. 22 in Chicago, IL, and Granger Medical Clinic on Oct. 19 in Salt Lake City, UT. Let’s walk in support of positive action for a #ProstateCancer PRO-STATE of Mind. For more information and to sign up, head here: bit.ly/4goSaLN #ZEROout #ZEROoutprostatecancer #ProstateCancerAwareness #ImPROstateofmind

September is Prostate Cancer Awareness Month, a time to focus on the special health needs of men everywhere. A time to know the facts and get screened. Support those who are affected. Understand all the treatment options. That’s what we call having a PRO-STATE of Mind. Because at Accord BioPharma, our goal is to go beyond biology and improve the patient experience throughout their journey. And that includes men living with prostate cancer—and their loved ones. ­­ #StayTuned to learn more about having a PRO-STATE of Mind. bit.ly/4goSaLN #PROstate #ImPROstateofmind #PROstateofmind #PROstatefacts #ProstateCancer #ProstateCancerAwareness #ProstateCancerAwarenessMonth